ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 227 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $22,615,401 | -3.2% | 2,960,131 | -9.7% | 0.30% | -10.4% |
| Q3 2022 | $23,351,000 | -18.4% | 3,279,620 | -7.3% | 0.34% | -17.3% |
| Q2 2022 | $28,631,000 | -34.4% | 3,539,055 | +12.5% | 0.40% | -20.1% |
| Q1 2022 | $43,657,000 | -21.0% | 3,145,293 | +59.8% | 0.51% | -10.9% |
| Q4 2021 | $55,234,000 | +21.6% | 1,968,431 | +47.3% | 0.57% | +23.4% |
| Q3 2021 | $45,411,000 | +15.5% | 1,336,023 | +38.8% | 0.46% | +20.1% |
| Q2 2021 | $39,322,000 | – | 962,352 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
| BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
| Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
| Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
| Triatomic Management LP | 121,166 | $813,024 | 0.83% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
| Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
| Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
| ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
| Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |